Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Continuing education programs significantly increased rural nurse practitioners' knowledge about PCOS.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.